News – Page 921 – Endpoints News

Remember that post-marketing trial? New study confirms many drugmakers don’t do them — half drag their feet

6 years ago

On track for first autoimmune drug approval, Bing Yao steers AstraZeneca spinoff to $150M IPO

6 years ago

Mylan wins tentative US approval for generic version of Lilly's Alimta — it could be years before it can be sold

6 years ago

Novartis preps a 2020 launch in multiple sclerosis as 2 successful pivotal trials set stage for an assault on ...

6 years ago

Academics and researchers raise concerns with FDA’s plan for ‘integrated reviews’

6 years ago

Immunicum's dendritic cell therapy flunks co-primary endpoint in 'positive' PhII

6 years ago

Esperion releases positive PhII results; Safety warnings at India, China manufacturing sites spell trouble for global ...

6 years ago

AbbVie’s $10B Rova-T play ends in one last failure — R&D team shuts it all down

6 years ago

EMA follows FDA to approve Roche's Tecentriq combo for frontline use in triple negative breast cancer

6 years ago

After disappointing investors, SillaJen gets into trouble with Korean prosecutors on suspected insider trading

6 years ago

FDA finalizes guidance on placebos and blinding for cancer trials

6 years ago

In a battered field, AstraZeneca's lupus drug clears pivotal study — but can they get it approved now?

6 years ago

Amgen’s legendary lawyer corps loses a major court fight attempting to quash PCSK9 rival from Sanofi, Regeneron

6 years ago

FDA fires off a warning on rare cases involving death, adverse liver events linked to misuse of 3 big hep C drugs

6 years ago

Tears for FAERS: Another FAERS disaster rumor slams Vertex shares in a Wall Street melee — but this time the ...

6 years ago

Kite partner HiFiBiO closes $67M round for preclinical antibody candidates churned out of single-cell analytics ...

6 years ago

Alexion's cash cow receives label expansion; Matthew Dallas tapped to CFO post at Zealand Pharma

6 years ago

Bristol-Myers, AbbVie's multiple myeloma drug wins second EU nod as part of triple regimen

6 years ago

The Woodford effect: Teetering on the edge, his co-investors are feeling the pain — and they want it to stop

6 years ago

AstraZeneca wins a round in their PhIII COPD bout with GSK — but can they catch up?

6 years ago

Purdue Pharma proposes $12B settlement to clean up opioid mess — report

6 years ago

Decades in the making, Kyowa Hakko Kirin finally wins FDA approval for add-on Parkinson's therapy

6 years ago

Immatics scores $75M upfront in TCR deal with Celgene as interest in tech burgeons

6 years ago

Top FDA exec Edward Cox jumps ship and joins Regeneron as new regulatory VP

6 years ago

First page Previous page 918 919 920921922 923 924 Next page Last page